Literature DB >> 31005342

Linear morphea: Clinical characteristics, disease course, and treatment of the Morphea in Adults and Children cohort.

Elaine Kunzler1, Stephanie Florez-Pollack2, Noelle Teske2, Jack O'Brien2, Smriti Prasad2, Heidi Jacobe3.   

Abstract

BACKGROUND: Prospective, longitudinal studies examining the features of linear morphea are limited.
OBJECTIVE: To utilize the Morphea in Adults and Children cohort to determine clinical characteristics, impact on life quality, and disease course of linear morphea in a prospective, longitudinal manner.
METHODS: Characteristics of linear morphea versus other subtypes were compared in a cross-sectional manner. Next, linear morphea participants were examined in depth over a 3-year period.
RESULTS: Linear morphea was the most common morphea subtype (50.1%, 291/581) in the cohort. Deep involvement was more common in linear (64.3%, 187/291) than other morphea subtypes. Linear morphea participants with deep involvement were more likely to have a limitation in range of motion (28.6%, 55/192) than those without (11.1%, 11/99, P < .001). Adult-onset disease occurred in 32.6% (95/291) of those with linear morphea. Frequency of deep involvement was similar between pediatric (66.8%, 131/196) and adult-onset linear morphea (58.9%, 56/95, P = .19). Quality of life and disease activity scores improved over time, while damage stabilized with treatment. LIMITATIONS: Results of the study are associative, and the University of Texas Southwestern Medical Center is a tertiary referral center.
CONCLUSION: A substantial number of linear morphea patients have adult-onset disease. In all age groups, linear morphea with deep involvement was associated with functional limitations.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MAC cohort; Morphea in Adults and Children cohort; Parry-Romberg syndrome; en coup de sabre; linear morphea; localized scleroderma; quality of life

Mesh:

Year:  2019        PMID: 31005342     DOI: 10.1016/j.jaad.2019.01.050

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

1.  Unilateral Linear Induration of the Skin: A Case Report of an Unusual Presentation of Scleredema.

Authors:  Jihan Muhaidat; Firas Al-Qarqaz; Diala Alshiyab
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

2.  Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre.

Authors:  Amanda M Saracino; Christina George; Svetlana I Nihtyanova; Christopher P Denton
Journal:  J Scleroderma Relat Disord       Date:  2020-06-12

3.  Linear Morphea: A Mimicker of Motor Neuron Disease.

Authors:  Rajat Manchanda; Govind Madhaw; Ritu Shree; Divya M Radhakrishnan; Arvind Kumar; Niraj Kumar
Journal:  Ann Indian Acad Neurol       Date:  2022-01-07       Impact factor: 1.714

4.  Changes in Disease Activity and Damage Over Time in Patients With Morphea.

Authors:  Jack C O'Brien; Hugh Nymeyer; Allison Green; Heidi T Jacobe
Journal:  JAMA Dermatol       Date:  2020-05-01       Impact factor: 10.282

Review 5.  Quality of Life in Patients with Morphea: A Cross-Sectional Study and a Review of the Current Literature.

Authors:  Justyna Szczęch; Dominik Samotij; Kamila Jaworecka; Aleksandra Tobiasz; Adam Reich
Journal:  Biomed Res Int       Date:  2020-03-13       Impact factor: 3.411

Review 6.  Morphea: progress to date and the road ahead.

Authors:  Laila Abbas; Adrienne Joseph; Elaine Kunzler; Heidi T Jacobe
Journal:  Ann Transl Med       Date:  2021-03

7.  A Case of Recalcitrant Linear Morphea Responding to Subcutaneous Abatacept.

Authors:  Jordan Talia; Carole Bitar; Yue Wang; Michael L Whitfield; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2021-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.